IPSCCentury Therapeutics, Inc.
- Market cap
- $264.37M
- as of 2026-10-23
- Latest close
- $1.46
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-11-03
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Carr DouglasSVP Finance & Operations | Sep 14 | Sep 15 | S | 1,658 | $1.93 | Sale −$3,200 | 502,907 | No | Form 4 |
| Russotti GregorySee Remarks | Sep 14 | Sep 15 | S | 2,587 | $1.93 | Sale −$4,993 | 509,198 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Sep 11 | Sep 15 | F | 13,850 | $1.94 | $26,869 | 3,633,839 | No | Form 4 |
| Truitt Joseph | Sep 9 | Sep 10 | A · derivative | 148,000 | $2.03 | $300,440 | 148,000 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Sep 8 | Sep 9 | S | 254 | $2.05 | Sale −$521 | 504,565 | No | Form 4 |
| Russotti GregorySee Remarks | Sep 8 | Sep 9 | S | 534 | $2.05 | Sale −$1,095 | 511,785 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Sep 4 | Sep 9 | F | 463 | $2.11 | $977 | 3,633,839 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Aug 14 | Aug 18 | F | 31,172 | $1.92 | $59,850 | 3,634,302 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Aug 3 | Aug 5 | S | 275 | $1.98 | Sale −$545 | 504,819 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Jun 12 | Jun 15 | S | 1,654 | $2.23 | Sale −$3,688 | 505,094 | No | Form 4 |
| Russotti GregorySee Remarks | Jun 12 | Jun 15 | S | 2,584 | $2.23 | Sale −$5,762 | 512,319 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Jun 11 | Jun 15 | F | 13,849 | $2.24 | $31,022 | 3,665,474 | No | Form 4 |
| Cowan ChadChief Scientific Officer | Jun 11 | Jun 15 | F | 358 | $2.24 | $802 | 1,175,322 | No | Form 4 |
| Quimi Daphne | Jun 11 | Jun 12 | A · derivative | 74,000 | $2.24 | $165,760 | 74,000 | No | Form 4 |
| Blackwell Kimberly | Jun 11 | Jun 12 | A · derivative | 74,000 | $2.24 | $165,760 | 74,000 | No | Form 4 |
| Riva Alessandro | Jun 11 | Jun 12 | A · derivative | 74,000 | $2.24 | $165,760 | 74,000 | No | Form 4 |
| Lee Han Myung | Jun 11 | Jun 12 | A · derivative | 74,000 | $2.24 | $165,760 | 74,000 | No | Form 4 |
| Murphy Martin Patrick | Jun 11 | Jun 12 | A · derivative | 74,000 | $2.24 | $165,760 | 74,000 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Jun 8 | Jun 9 | S | 249 | $2.11 | Sale −$525 | 506,748 | No | Form 4 |
| Russotti GregorySee Remarks | Jun 8 | Jun 9 | S | 524 | $2.11 | Sale −$1,106 | 514,903 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Jun 5 | Jun 9 | F | 463 | $2.13 | $986 | 3,679,323 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | May 15 | May 19 | F | 31,172 | $2.34 | $72,942 | 3,679,786 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | May 4 | May 6 | S | 264 | $2.34 | Sale −$618 | 506,997 | No | Form 4 |
| Murphy Martin Patrick | Dec 9, 2025 | Apr 10 | A · derivative | 88,000 | $0.59 | $51,920 | 88,000 | No | Form 4 |
| Cowan ChadChief Scientific Officer | Apr 1 | Apr 3 | F | 1,365 | $2.19 | $2,989 | 1,175,680 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Mar 12 | Mar 16 | S | 7,043 | $2.55 | Sale −$17,960 | 507,261 | No | Form 4 |
| Russotti GregorySee Remarks | Mar 12 | Mar 16 | S | 10,076 | $2.55 | Sale −$25,694 | 515,427 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Mar 11 | Mar 13 | F | 55,397 | $2.73 | $151,234 | 3,710,958 | No | Form 4 |
| Cowan ChadChief Scientific Officer | Mar 11 | Mar 13 | F | 1,431 | $2.73 | $3,907 | 1,177,045 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Mar 9 | Mar 11 | S | 247 | $2.54 | Sale −$627 | 514,304 | No | Form 4 |
| Russotti GregorySee Remarks | Mar 9 | Mar 11 | S | 479 | $2.54 | Sale −$1,217 | 525,503 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Mar 6 | Mar 10 | F | 463 | $2.56 | $1,185 | 3,766,355 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Feb 13 | Feb 18 | F | 31,172 | $1.75 | $54,551 | 3,766,818 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Feb 3 | Feb 5 | S | 323 | $1.82 | Sale −$588 | 514,551 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Feb 2 | Feb 4 | A | 110,000 | $0.00 | $0 | 514,874 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Feb 2 | Feb 4 | A · derivative | 225,000 | $1.84 | $414,000 | 225,000 | No | Form 4 |
| Russotti GregorySee Remarks | Feb 2 | Feb 4 | A | 135,000 | $0.00 | $0 | 525,982 | No | Form 4 |
| Russotti GregorySee Remarks | Feb 2 | Feb 4 | A · derivative | 265,000 | $1.84 | $487,600 | 265,000 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Feb 2 | Feb 4 | A | 475,000 | $0.00 | $0 | 3,797,990 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Feb 2 | Feb 4 | A · derivative | 945,000 | $1.84 | $1,738,800 | 945,000 | No | Form 4 |
| Cowan ChadChief Scientific Officer | Feb 2 | Feb 4 | A | 135,000 | $0.00 | $0 | 1,178,476 | No | Form 4 |
| Cowan ChadChief Scientific Officer | Feb 2 | Feb 4 | A · derivative | 265,000 | $1.84 | $487,600 | 265,000 | No | Form 4 |
| Cowan ChadChief Scientific Officer | Jan 2 | Jan 6 | F | 1,611 | $1.00 | $1,611 | 1,043,476 | No | Form 4 |
| Cowan ChadChief Scientific Officer | Dec 22, 2025 | Dec 29, 2025 | P | 58,060 | $0.85 | Purchase +$49,351 | 1,045,087 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Dec 12, 2025 | Dec 16, 2025 | P | 52,000 | $0.58 | Purchase +$30,160 | 3,322,990 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Dec 10, 2025 | Dec 12, 2025 | F | 463 | $0.53 | $245 | 3,270,990 | No | Form 4 |
| Lee Han Myung | Dec 9, 2025 | Dec 11, 2025 | A · derivative | 88,000 | $0.59 | $51,920 | 88,000 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Dec 8, 2025 | Dec 10, 2025 | S | 257 | $0.53 | Sale −$136 | 404,874 | No | Form 4 |
| Russotti GregorySee Remarks | Dec 8, 2025 | Dec 10, 2025 | S | 526 | $0.53 | Sale −$279 | 390,982 | No | Form 4 |
| Cowan ChadChief Scientific Officer | Nov 20, 2025 | Nov 24, 2025 | S | 5,462 | $0.50 | Sale −$2,731 | 987,027 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Nov 19, 2025 | Nov 20, 2025 | P | 35,000 | $0.50 | Purchase +$17,500 | 3,271,453 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Nov 17, 2025 | Nov 19, 2025 | S | 32,456 | $0.45 | Sale −$14,605 | 3,236,453 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Nov 3, 2025 | Nov 5, 2025 | S | 292 | $0.59 | Sale −$172 | 405,131 | No | Form 4 |
| Cowan ChadChief Scientific Officer | Sep 18, 2025 | Sep 22, 2025 | A | 762,543 | $0.00 | $0 | 992,489 | No | Form 4 |
| Russotti GregorySee Remarks | Sep 8, 2025 | Sep 10, 2025 | S | 539 | $0.50 | Sale −$270 | 391,508 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Sep 8, 2025 | Sep 10, 2025 | S | 488 | $0.50 | Sale −$244 | 3,268,909 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Sep 8, 2025 | Sep 10, 2025 | S | 263 | $0.50 | Sale −$132 | 405,423 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Aug 14, 2025 | Aug 18, 2025 | A | 1,587,614 | $0.00 | $0 | 3,269,397 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Aug 4, 2025 | Aug 6, 2025 | S | 296 | $0.53 | Sale −$157 | 405,686 | No | Form 4 |
| Walbert Timothy P | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 44,000 | $0.60 | $26,400 | 44,000 | No | Form 4 |
| Butitta Cynthia M | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 44,000 | $0.60 | $26,400 | 44,000 | No | Form 4 |
| Quimi Daphne | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 44,000 | $0.60 | $26,400 | 44,000 | No | Form 4 |
| Carlo Rizzuto | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 44,000 | $0.60 | $26,400 | 44,000 | No | Form 4 |
| Riva Alessandro | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 44,000 | $0.60 | $26,400 | 44,000 | No | Form 4 |
| Jimenez Joseph | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 44,000 | $0.60 | $26,400 | 44,000 | No | Form 4 |
| Blackwell Kimberly | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 44,000 | $0.60 | $26,400 | 44,000 | No | Form 4 |
| Russotti GregorySee Remarks | Jun 9, 2025 | Jun 11, 2025 | S | 526 | $0.62 | Sale −$326 | 392,047 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Jun 9, 2025 | Jun 11, 2025 | S | 475 | $0.62 | Sale −$295 | 1,681,783 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Jun 9, 2025 | Jun 11, 2025 | S | 552 | $0.62 | Sale −$342 | 250,141 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Jun 9, 2025 | Jun 11, 2025 | S | 4,904 | $0.62 | Sale −$3,040 | 405,982 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | May 16, 2025 | May 20, 2025 | S | 29,552 | $0.55 | Sale −$16,254 | 1,682,258 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | May 5, 2025 | May 7, 2025 | S | 295 | $0.55 | Sale −$162 | 410,886 | No | Form 4 |
| Farid AdrienneChief Operations Officer | May 5, 2025 | May 7, 2025 | S | 1,024 | $0.55 | Sale −$563 | 250,693 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Mar 11, 2025 | Mar 12, 2025 | A | 95,625 | $0.00 | $0 | 411,181 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Mar 11, 2025 | Mar 12, 2025 | A · derivative | 95,625 | $0.60 | $57,375 | 95,625 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Mar 11, 2025 | Mar 12, 2025 | A | 120,000 | $0.00 | $0 | 251,717 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Mar 11, 2025 | Mar 12, 2025 | A · derivative | 120,000 | $0.60 | $72,000 | 120,000 | No | Form 4 |
| Russotti GregorySee Remarks | Mar 11, 2025 | Mar 12, 2025 | A | 120,000 | $0.00 | $0 | 392,573 | No | Form 4 |
| Russotti GregorySee Remarks | Mar 11, 2025 | Mar 12, 2025 | A · derivative | 120,000 | $0.60 | $72,000 | 120,000 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Mar 11, 2025 | Mar 12, 2025 | A | 521,500 | $0.00 | $0 | 1,711,810 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Mar 11, 2025 | Mar 12, 2025 | A · derivative | 521,500 | $0.60 | $312,900 | 521,500 | No | Form 4 |
| Cowan ChadChief Scientific Officer | Mar 11, 2025 | Mar 12, 2025 | A | 19,500 | $0.00 | $0 | 230,306 | No | Form 4 |
| Cowan ChadChief Scientific Officer | Mar 11, 2025 | Mar 12, 2025 | A · derivative | 19,500 | $0.60 | $11,700 | 19,500 | No | Form 4 |
| Conn MorganChief Finanical Officer | Mar 11, 2025 | Mar 12, 2025 | A | 19,500 | $0.00 | $0 | 79,648 | No | Form 4 |
| Conn MorganChief Finanical Officer | Mar 11, 2025 | Mar 12, 2025 | A · derivative | 19,500 | $0.60 | $11,700 | 19,500 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Mar 10, 2025 | Mar 12, 2025 | S | 1,240 | $0.62 | Sale −$769 | 315,556 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Mar 10, 2025 | Mar 12, 2025 | S | 2,359 | $0.62 | Sale −$1,463 | 131,717 | No | Form 4 |
| Russotti GregorySee Remarks | Mar 10, 2025 | Mar 12, 2025 | S | 2,360 | $0.62 | Sale −$1,463 | 272,573 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Mar 10, 2025 | Mar 12, 2025 | S | 2,235 | $0.62 | Sale −$1,386 | 1,190,310 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Feb 18, 2025 | Feb 20, 2025 | S | 34,712 | $0.78 | Sale −$27,075 | 1,192,545 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Feb 3, 2025 | Feb 5, 2025 | S | 351 | $0.78 | Sale −$274 | 316,796 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Feb 3, 2025 | Feb 5, 2025 | S | 1,054 | $0.78 | Sale −$822 | 134,076 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Dec 4, 2024 | Dec 6, 2024 | F | 243,447 | $1.44 | $350,564 | 1,227,257 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Nov 4, 2024 | Nov 5, 2024 | S | 283 | $1.23 | Sale −$348 | 317,147 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Nov 4, 2024 | Nov 5, 2024 | S | 1,033 | $1.23 | Sale −$1,271 | 135,130 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Nov 1, 2024 | Nov 5, 2024 | F | 16,611 | $1.26 | $20,930 | 317,430 | No | Form 4 |
| Conn MorganChief Finanical Officer | Oct 14, 2024 | Oct 16, 2024 | A | 60,148 | $0.00 | $0 | 60,148 | No | Form 4 |
| Conn MorganChief Finanical Officer | Oct 14, 2024 | Oct 16, 2024 | A · derivative | 360,890 | $1.48 | $534,117 | 360,890 | No | Form 4 |
| Cowan ChadChief Scientific Officer | Oct 1, 2024 | Oct 3, 2024 | A | 74,376 | $0.00 | $0 | 210,806 | No | Form 4 |
| Cowan ChadChief Scientific Officer | Oct 1, 2024 | Oct 3, 2024 | A · derivative | 446,250 | $1.65 | $736,313 | 446,250 | No | Form 4 |
| Quimi Daphne | Sep 12, 2024 | Sep 16, 2024 | P | 5,000 | $1.53 | Purchase +$7,650 | 5,000 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Aug 5, 2024 | Aug 7, 2024 | S | 289 | $1.83 | Sale −$529 | 334,041 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Aug 5, 2024 | Aug 7, 2024 | S | 1,073 | $1.83 | Sale −$1,964 | 136,163 | No | Form 4 |
| Russotti GregorySee Remarks | Jul 26, 2024 | Jul 31, 2024 | S | 586 | $2.50 | Sale −$1,465 | 274,933 | Yes | Form 4 |
| Russotti GregorySee Remarks | Jul 24, 2024 | Jul 25, 2024 | S | 1,600 | $2.52 | Sale −$4,032 | 275,519 | Yes | Form 4 |
| Russotti GregorySee Remarks | Jul 23, 2024 | Jul 25, 2024 | S | 200 | $2.50 | Sale −$500 | 277,119 | Yes | Form 4 |
| Russotti GregorySee Remarks | Jun 20, 2024 | Jun 24, 2024 | S | 5,000 | $2.84 | Sale −$14,200 | 277,319 | Yes | Form 4 |
| Blackwell Kimberly | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 44,000 | $2.69 | $118,360 | 44,000 | No | Form 4 |
| Carlo Rizzuto | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 44,000 | $2.69 | $118,360 | 44,000 | No | Form 4 |
| Riva Alessandro | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 44,000 | $2.69 | $118,360 | 44,000 | No | Form 4 |
| Butitta Cynthia M | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 44,000 | $2.69 | $118,360 | 44,000 | No | Form 4 |
| Quimi Daphne | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 44,000 | $2.69 | $118,360 | 44,000 | No | Form 4 |
| Walbert Timothy P | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 44,000 | $2.69 | $118,360 | 44,000 | No | Form 4 |
| Jimenez Joseph | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 44,000 | $2.69 | $118,360 | 44,000 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Jun 7, 2024 | Jun 10, 2024 | A | 17,007 | $0.00 | $0 | 334,330 | No | Form 4 |
| Russotti GregorySee Remarks | Jun 5, 2024 | Jun 6, 2024 | S | 5,000 | $3.00 | Sale −$15,000 | 282,319 | Yes | Form 4 |
| Russotti GregorySee Remarks | May 20, 2024 | May 21, 2024 | S | 5,000 | $3.00 | Sale −$15,000 | 287,319 | Yes | Form 4 |
| Russotti GregorySee Remarks | May 6, 2024 | May 7, 2024 | S | 5,000 | $3.12 | Sale −$15,600 | 292,319 | Yes | Form 4 |
| Farid AdrienneChief Operations Officer | May 3, 2024 | May 7, 2024 | S | 913 | $3.11 | Sale −$2,839 | 137,236 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | May 3, 2024 | May 7, 2024 | S | 257 | $3.11 | Sale −$799 | 317,323 | No | Form 4 |
| Russotti GregorySee Remarks | Apr 22, 2024 | Apr 24, 2024 | S | 5,000 | $3.10 | Sale −$15,500 | 297,319 | Yes | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Mar 7, 2024 | Mar 18, 2024 | A | 17,425 | $0.00 | $0 | 1,470,704 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Mar 7, 2024 | Mar 18, 2024 | A · derivative | 104,550 | $5.32 | $556,206 | 104,550 | No | Form 4 |
| Levitsky HyamPresident of R&D | Mar 7, 2024 | Mar 11, 2024 | A | 24,000 | $0.00 | $0 | 24,000 | No | Form 4 |
| Levitsky HyamPresident of R&D | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 146,000 | $5.32 | $776,720 | 146,000 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Mar 7, 2024 | Mar 11, 2024 | A | 24,000 | $0.00 | $0 | 138,149 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 146,000 | $5.32 | $776,720 | 146,000 | No | Form 4 |
| Russotti GregorySee Remarks | Mar 7, 2024 | Mar 11, 2024 | A | 24,000 | $0.00 | $0 | 302,319 | No | Form 4 |
| Russotti GregorySee Remarks | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 146,000 | $5.32 | $776,720 | 146,000 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Mar 7, 2024 | Mar 11, 2024 | A | 14,000 | $0.00 | $0 | 317,580 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 81,000 | $5.32 | $430,920 | 81,000 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Mar 7, 2024 | Mar 8, 2024 | M | 22,831 | $1.03 | $23,516 | 136,980 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Mar 7, 2024 | Mar 8, 2024 | S | 22,831 | $5.14 | Sale −$117,351 | 114,149 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Mar 7, 2024 | Mar 8, 2024 | M · derivative | 22,831 | $1.03 | $23,516 | 168,655 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Mar 6, 2024 | Mar 8, 2024 | M | 30,684 | $1.03 | $31,605 | 144,833 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Mar 6, 2024 | Mar 8, 2024 | S | 30,684 | $4.96 | Sale −$152,193 | 114,149 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Mar 6, 2024 | Mar 8, 2024 | M · derivative | 30,684 | $1.03 | $31,605 | 191,486 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Feb 16, 2024 | Feb 21, 2024 | M | 485 | $1.03 | $500 | 114,634 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Feb 16, 2024 | Feb 21, 2024 | S | 485 | $4.86 | Sale −$2,357 | 114,149 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Feb 16, 2024 | Feb 21, 2024 | M · derivative | 485 | $1.03 | $500 | 222,170 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Feb 6, 2024 | Feb 7, 2024 | S | 1,784 | $4.49 | Sale −$8,010 | 114,149 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Feb 6, 2024 | Feb 7, 2024 | S | 557 | $4.49 | Sale −$2,501 | 303,580 | No | Form 4 |
| Farid AdrienneChief Operations Officer | Feb 5, 2024 | Feb 7, 2024 | S | 2,035 | $3.84 | Sale −$7,814 | 115,933 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Feb 5, 2024 | Feb 7, 2024 | S | 643 | $3.84 | Sale −$2,469 | 304,137 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Dec 4, 2023 | Dec 6, 2023 | A | 1,173,775 | $0.00 | $0 | 1,173,775 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Dec 4, 2023 | Dec 6, 2023 | A | 279,504 | $0.00 | $0 | 1,453,279 | No | Form 4 |
| Pfeiffenberger BrentPresident and CEO | Dec 4, 2023 | Dec 6, 2023 | A · derivative | 573,691 | $1.61 | $923,643 | 573,691 | No | Form 4 |
| Diem Michael CraigChief Financial Officer | Nov 1, 2023 | Nov 3, 2023 | F | 20,763 | $1.49 | $30,937 | 253,533 | No | Form 4 |
| Carr DouglasSVP Finance & Operations | Nov 1, 2023 | Nov 3, 2023 | F | 16,611 | $1.49 | $24,750 | 304,780 | No | Form 4 |